2021 Annual Meeting | Industry Therapeutic Update from Teva: Spotlight on AJOVY: The long-acting anti-CGRP injection with the option of dosing only 4 times a year
Program Materials Program Evaluations
No timeline events available at this time. |
Program Materials Program Evaluations
No timeline events available at this time. |